- Home
- CWST vs CRSP Comparison
CWST vs CRSP Comparison
Compare CWST & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- CRSP
- Stock Information
- Founded
- CWST 1975
- CRSP 2013
- Country
- CWST United States
- CRSP Switzerland
- Employees
- CWST N/A
- CRSP N/A
- Industry
- CWST Environmental Services
- CRSP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CWST Utilities
- CRSP Health Care
- Exchange
- CWST Nasdaq
- CRSP Nasdaq
- Market Cap
- CWST 5.8B
- CRSP 5.6B
- IPO Year
- CWST 1997
- CRSP 2016
- Fundamental
- Price
- CWST $89.98
- CRSP $56.41
- Analyst Decision
- CWST Strong Buy
- CRSP Buy
- Analyst Count
- CWST 8
- CRSP 18
- Target Price
- CWST $119.50
- CRSP $73.47
- AVG Volume (30 Days)
- CWST 545.0K
- CRSP 2.6M
- Earning Date
- CWST 10-30-2025
- CRSP 11-04-2025
- Dividend Yield
- CWST N/A
- CRSP N/A
- EPS Growth
- CWST 102.54
- CRSP N/A
- EPS
- CWST 0.24
- CRSP N/A
- Revenue
- CWST $1,795,272,000.00
- CRSP $38,050,000.00
- Revenue This Year
- CWST $20.21
- CRSP N/A
- Revenue Next Year
- CWST $7.48
- CRSP $391.94
- P/E Ratio
- CWST $377.65
- CRSP N/A
- Revenue Growth
- CWST 20.54
- CRSP N/A
- 52 Week Low
- CWST $82.22
- CRSP $30.04
- 52 Week High
- CWST $121.24
- CRSP $78.48
- Technical
- Relative Strength Index (RSI)
- CWST 51.88
- CRSP 36.06
- Support Level
- CWST $82.22
- CRSP $64.80
- Resistance Level
- CWST $89.04
- CRSP $65.98
- Average True Range (ATR)
- CWST 2.62
- CRSP 3.49
- MACD
- CWST 0.39
- CRSP -1.58
- Stochastic Oscillator
- CWST 83.62
- CRSP 2.15
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About CRSP CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.